The global Equine Drugs and Supplement market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Equine Drugs and Supplement manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Equine Drugs and Supplement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Drugs and Supplement. This report contains market size and forecasts of Equine Drugs and Supplement in global, including the following market information:
Global Equine Drugs and Supplement market revenue, 2020-2025, 2026-2031, ($ millions)
Global Equine Drugs and Supplement market sales, 2020-2025, 2026-2031, (K Units)
Global top five Equine Drugs and Supplement companies in 2024 (%)
Total Market by Segment:
Global Equine Drugs and Supplement market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Equine Drugs and Supplement market segment percentages, by Type, 2024 (%)
Supplements
Pharmaceutical Drugs
Global Equine Drugs and Supplement market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Equine Drugs and Supplement market segment percentages, by Application, 2024 (%)
Drugstores
Veterinary Hospitals
Others
Global Equine Drugs and Supplement market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Equine Drugs and Supplement market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Equine Drugs and Supplement revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Equine Drugs and Supplement revenues share in global market, 2024 (%)
Key companies Equine Drugs and Supplement sales in global market, 2020-2025 (estimated), (K Units)
Key companies Equine Drugs and Supplement sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Animal Health
Boehringer Ingelheim
Elanco (Eli Lilly)
Merck Animal Health
Merial
Novartis Animal Health
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Equine Drugs and Supplement, market overview.
Chapter 2: Global Equine Drugs and Supplement market size in revenue and volume.
Chapter 3: Detailed analysis of Equine Drugs and Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Equine Drugs and Supplement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Equine Drugs and Supplement capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Equine Drugs and Supplement Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Equine Drugs and Supplement Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Equine Drugs and Supplement Overall Market Size
2.1 Global Equine Drugs and Supplement Market Size: 2024 VS 2031
2.2 Global Equine Drugs and Supplement Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Equine Drugs and Supplement Sales: 2020-2031
3 Company Landscape
3.1 Top Equine Drugs and Supplement Players in Global Market
3.2 Top Global Equine Drugs and Supplement Companies Ranked by Revenue
3.3 Global Equine Drugs and Supplement Revenue by Companies
3.4 Global Equine Drugs and Supplement Sales by Companies
3.5 Global Equine Drugs and Supplement Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Equine Drugs and Supplement Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Equine Drugs and Supplement Product Type
3.8 Tier 1, Tier 2, and Tier 3 Equine Drugs and Supplement Players in Global Market
3.8.1 List of Global Tier 1 Equine Drugs and Supplement Companies
3.8.2 List of Global Tier 2 and Tier 3 Equine Drugs and Supplement Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Equine Drugs and Supplement Market Size Markets, 2024 & 2031
4.1.2 Supplements
4.1.3 Pharmaceutical Drugs
4.2 Segment by Type - Global Equine Drugs and Supplement Revenue & Forecasts
4.2.1 Segment by Type - Global Equine Drugs and Supplement Revenue, 2020-2025
4.2.2 Segment by Type - Global Equine Drugs and Supplement Revenue, 2026-2031
4.2.3 Segment by Type - Global Equine Drugs and Supplement Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Equine Drugs and Supplement Sales & Forecasts
4.3.1 Segment by Type - Global Equine Drugs and Supplement Sales, 2020-2025
4.3.2 Segment by Type - Global Equine Drugs and Supplement Sales, 2026-2031
4.3.3 Segment by Type - Global Equine Drugs and Supplement Sales Market Share, 2020-2031
4.4 Segment by Type - Global Equine Drugs and Supplement Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Equine Drugs and Supplement Market Size, 2024 & 2031
5.1.2 Drugstores
5.1.3 Veterinary Hospitals
5.1.4 Others
5.2 Segment by Application - Global Equine Drugs and Supplement Revenue & Forecasts
5.2.1 Segment by Application - Global Equine Drugs and Supplement Revenue, 2020-2025
5.2.2 Segment by Application - Global Equine Drugs and Supplement Revenue, 2026-2031
5.2.3 Segment by Application - Global Equine Drugs and Supplement Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Equine Drugs and Supplement Sales & Forecasts
5.3.1 Segment by Application - Global Equine Drugs and Supplement Sales, 2020-2025
5.3.2 Segment by Application - Global Equine Drugs and Supplement Sales, 2026-2031
5.3.3 Segment by Application - Global Equine Drugs and Supplement Sales Market Share, 2020-2031
5.4 Segment by Application - Global Equine Drugs and Supplement Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Equine Drugs and Supplement Market Size, 2024 & 2031
6.2 By Region - Global Equine Drugs and Supplement Revenue & Forecasts
6.2.1 By Region - Global Equine Drugs and Supplement Revenue, 2020-2025
6.2.2 By Region - Global Equine Drugs and Supplement Revenue, 2026-2031
6.2.3 By Region - Global Equine Drugs and Supplement Revenue Market Share, 2020-2031
6.3 By Region - Global Equine Drugs and Supplement Sales & Forecasts
6.3.1 By Region - Global Equine Drugs and Supplement Sales, 2020-2025
6.3.2 By Region - Global Equine Drugs and Supplement Sales, 2026-2031
6.3.3 By Region - Global Equine Drugs and Supplement Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Equine Drugs and Supplement Revenue, 2020-2031
6.4.2 By Country - North America Equine Drugs and Supplement Sales, 2020-2031
6.4.3 United States Equine Drugs and Supplement Market Size, 2020-2031
6.4.4 Canada Equine Drugs and Supplement Market Size, 2020-2031
6.4.5 Mexico Equine Drugs and Supplement Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Equine Drugs and Supplement Revenue, 2020-2031
6.5.2 By Country - Europe Equine Drugs and Supplement Sales, 2020-2031
6.5.3 Germany Equine Drugs and Supplement Market Size, 2020-2031
6.5.4 France Equine Drugs and Supplement Market Size, 2020-2031
6.5.5 U.K. Equine Drugs and Supplement Market Size, 2020-2031
6.5.6 Italy Equine Drugs and Supplement Market Size, 2020-2031
6.5.7 Russia Equine Drugs and Supplement Market Size, 2020-2031
6.5.8 Nordic Countries Equine Drugs and Supplement Market Size, 2020-2031
6.5.9 Benelux Equine Drugs and Supplement Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Equine Drugs and Supplement Revenue, 2020-2031
6.6.2 By Region - Asia Equine Drugs and Supplement Sales, 2020-2031
6.6.3 China Equine Drugs and Supplement Market Size, 2020-2031
6.6.4 Japan Equine Drugs and Supplement Market Size, 2020-2031
6.6.5 South Korea Equine Drugs and Supplement Market Size, 2020-2031
6.6.6 Southeast Asia Equine Drugs and Supplement Market Size, 2020-2031
6.6.7 India Equine Drugs and Supplement Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Equine Drugs and Supplement Revenue, 2020-2031
6.7.2 By Country - South America Equine Drugs and Supplement Sales, 2020-2031
6.7.3 Brazil Equine Drugs and Supplement Market Size, 2020-2031
6.7.4 Argentina Equine Drugs and Supplement Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Equine Drugs and Supplement Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Equine Drugs and Supplement Sales, 2020-2031
6.8.3 Turkey Equine Drugs and Supplement Market Size, 2020-2031
6.8.4 Israel Equine Drugs and Supplement Market Size, 2020-2031
6.8.5 Saudi Arabia Equine Drugs and Supplement Market Size, 2020-2031
6.8.6 UAE Equine Drugs and Supplement Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Bayer Animal Health
7.1.1 Bayer Animal Health Company Summary
7.1.2 Bayer Animal Health Business Overview
7.1.3 Bayer Animal Health Equine Drugs and Supplement Major Product Offerings
7.1.4 Bayer Animal Health Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.1.5 Bayer Animal Health Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Equine Drugs and Supplement Major Product Offerings
7.2.4 Boehringer Ingelheim Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Elanco (Eli Lilly)
7.3.1 Elanco (Eli Lilly) Company Summary
7.3.2 Elanco (Eli Lilly) Business Overview
7.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Major Product Offerings
7.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.3.5 Elanco (Eli Lilly) Key News & Latest Developments
7.4 Merck Animal Health
7.4.1 Merck Animal Health Company Summary
7.4.2 Merck Animal Health Business Overview
7.4.3 Merck Animal Health Equine Drugs and Supplement Major Product Offerings
7.4.4 Merck Animal Health Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.4.5 Merck Animal Health Key News & Latest Developments
7.5 Merial
7.5.1 Merial Company Summary
7.5.2 Merial Business Overview
7.5.3 Merial Equine Drugs and Supplement Major Product Offerings
7.5.4 Merial Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.5.5 Merial Key News & Latest Developments
7.6 Novartis Animal Health
7.6.1 Novartis Animal Health Company Summary
7.6.2 Novartis Animal Health Business Overview
7.6.3 Novartis Animal Health Equine Drugs and Supplement Major Product Offerings
7.6.4 Novartis Animal Health Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.6.5 Novartis Animal Health Key News & Latest Developments
7.7 Zoetis
7.7.1 Zoetis Company Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Equine Drugs and Supplement Major Product Offerings
7.7.4 Zoetis Equine Drugs and Supplement Sales and Revenue in Global (2020-2025)
7.7.5 Zoetis Key News & Latest Developments
8 Global Equine Drugs and Supplement Production Capacity, Analysis
8.1 Global Equine Drugs and Supplement Production Capacity, 2020-2031
8.2 Equine Drugs and Supplement Production Capacity of Key Manufacturers in Global Market
8.3 Global Equine Drugs and Supplement Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Equine Drugs and Supplement Supply Chain Analysis
10.1 Equine Drugs and Supplement Industry Value Chain
10.2 Equine Drugs and Supplement Upstream Market
10.3 Equine Drugs and Supplement Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Equine Drugs and Supplement Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Equine Drugs and Supplement in Global Market
Table 2. Top Equine Drugs and Supplement Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Equine Drugs and Supplement Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Equine Drugs and Supplement Revenue Share by Companies, 2020-2025
Table 5. Global Equine Drugs and Supplement Sales by Companies, (K Units), 2020-2025
Table 6. Global Equine Drugs and Supplement Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Equine Drugs and Supplement Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Equine Drugs and Supplement Product Type
Table 9. List of Global Tier 1 Equine Drugs and Supplement Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Equine Drugs and Supplement Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Equine Drugs and Supplement Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Equine Drugs and Supplement Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Equine Drugs and Supplement Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Equine Drugs and Supplement Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Equine Drugs and Supplement Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Equine Drugs and Supplement Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 21. By Region – Global Equine Drugs and Supplement Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 25. By Region - Global Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 26. By Country - North America Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 29. By Country - North America Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 30. By Country - Europe Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 33. By Country - Europe Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 34. By Region - Asia Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 37. By Region - Asia Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 38. By Country - South America Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 41. By Country - South America Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Equine Drugs and Supplement Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Equine Drugs and Supplement Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Equine Drugs and Supplement Sales, (K Units), 2026-2031
Table 46. Bayer Animal Health Company Summary
Table 47. Bayer Animal Health Equine Drugs and Supplement Product Offerings
Table 48. Bayer Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Bayer Animal Health Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Equine Drugs and Supplement Product Offerings
Table 52. Boehringer Ingelheim Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Elanco (Eli Lilly) Company Summary
Table 55. Elanco (Eli Lilly) Equine Drugs and Supplement Product Offerings
Table 56. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Elanco (Eli Lilly) Key News & Latest Developments
Table 58. Merck Animal Health Company Summary
Table 59. Merck Animal Health Equine Drugs and Supplement Product Offerings
Table 60. Merck Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Merck Animal Health Key News & Latest Developments
Table 62. Merial Company Summary
Table 63. Merial Equine Drugs and Supplement Product Offerings
Table 64. Merial Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Merial Key News & Latest Developments
Table 66. Novartis Animal Health Company Summary
Table 67. Novartis Animal Health Equine Drugs and Supplement Product Offerings
Table 68. Novartis Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Novartis Animal Health Key News & Latest Developments
Table 70. Zoetis Company Summary
Table 71. Zoetis Equine Drugs and Supplement Product Offerings
Table 72. Zoetis Equine Drugs and Supplement Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Zoetis Key News & Latest Developments
Table 74. Equine Drugs and Supplement Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 75. Global Equine Drugs and Supplement Capacity Market Share of Key Manufacturers, 2023-2025
Table 76. Global Equine Drugs and Supplement Production by Region, 2020-2025 (K Units)
Table 77. Global Equine Drugs and Supplement Production by Region, 2026-2031 (K Units)
Table 78. Equine Drugs and Supplement Market Opportunities & Trends in Global Market
Table 79. Equine Drugs and Supplement Market Drivers in Global Market
Table 80. Equine Drugs and Supplement Market Restraints in Global Market
Table 81. Equine Drugs and Supplement Raw Materials
Table 82. Equine Drugs and Supplement Raw Materials Suppliers in Global Market
Table 83. Typical Equine Drugs and Supplement Downstream
Table 84. Equine Drugs and Supplement Downstream Clients in Global Market
Table 85. Equine Drugs and Supplement Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Equine Drugs and Supplement Product Picture
Figure 2. Equine Drugs and Supplement Segment by Type in 2024
Figure 3. Equine Drugs and Supplement Segment by Application in 2024
Figure 4. Global Equine Drugs and Supplement Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Equine Drugs and Supplement Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Equine Drugs and Supplement Revenue: 2020-2031 (US$, Mn)
Figure 8. Equine Drugs and Supplement Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Equine Drugs and Supplement Revenue in 2024
Figure 10. Segment by Type – Global Equine Drugs and Supplement Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Equine Drugs and Supplement Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Equine Drugs and Supplement Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Equine Drugs and Supplement Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Equine Drugs and Supplement Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Equine Drugs and Supplement Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Equine Drugs and Supplement Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Equine Drugs and Supplement Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 21. By Region - Global Equine Drugs and Supplement Sales Market Share, 2020-2031
Figure 22. By Country - North America Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 23. By Country - North America Equine Drugs and Supplement Sales Market Share, 2020-2031
Figure 24. United States Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Equine Drugs and Supplement Sales Market Share, 2020-2031
Figure 29. Germany Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 30. France Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Equine Drugs and Supplement Sales Market Share, 2020-2031
Figure 38. China Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 42. India Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Equine Drugs and Supplement Revenue Market Share, 2020-2031
Figure 44. By Country - South America Equine Drugs and Supplement Sales, Market Share, 2020-2031
Figure 45. Brazil Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Equine Drugs and Supplement Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Equine Drugs and Supplement Sales, Market Share, 2020-2031
Figure 49. Turkey Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Equine Drugs and Supplement Revenue, (US$, Mn), 2020-2031
Figure 53. Global Equine Drugs and Supplement Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Equine Drugs and Supplement by Region, 2024 VS 2031
Figure 55. Equine Drugs and Supplement Industry Value Chain
Figure 56. Marketing Channels
